134 related articles for article (PubMed ID: 8452360)
1. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
Dan M; Weidekamm E; Sagiv R; Portmann R; Zakut H
Antimicrob Agents Chemother; 1993 Feb; 37(2):293-6. PubMed ID: 8452360
[TBL] [Abstract][Full Text] [Related]
2. Influence of rifampin on fleroxacin pharmacokinetics.
Schrenzel J; Dayer P; Leemann T; Weidekamm E; Portmann R; Lew DP
Antimicrob Agents Chemother; 1993 Oct; 37(10):2132-8. PubMed ID: 8257135
[TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
Schrenzel J; Cerruti F; Herrmann M; Leemann T; Weidekamm E; Portmann R; Hirschel B; Lew DP
Antimicrob Agents Chemother; 1994 Jun; 38(6):1219-24. PubMed ID: 8092817
[TBL] [Abstract][Full Text] [Related]
4. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
Kim MK; Nightingale C; Nicolau D
Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
[TBL] [Abstract][Full Text] [Related]
5. Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women.
Korth-Bradley JM; Parks V; Chalon S; Gourley I; Matschke K; Gossart S; Bryson P; Fleckenstein L
Antimicrob Agents Chemother; 2011 Nov; 55(11):5200-4. PubMed ID: 21896908
[TBL] [Abstract][Full Text] [Related]
6. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
[TBL] [Abstract][Full Text] [Related]
8. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers.
Lubowski TJ; Nightingale CH; Sweeney K; Quintiliani R
Antimicrob Agents Chemother; 1992 Dec; 36(12):2758-60. PubMed ID: 1482143
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of fleroxacin in renal impairment.
Weidekamm E
Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
[TBL] [Abstract][Full Text] [Related]
10. Fleroxacin pharmacokinetics in patients with liver cirrhosis.
Blouin RA; Hamelin BA; Smith DA; Foster TS; John WJ; Welker HA
Antimicrob Agents Chemother; 1992 Mar; 36(3):632-8. PubMed ID: 1622175
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Panneton AC; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
Chukwuani CM; Coker HA; Oduola AM; Sowunmi A; Ifudu ND
Biol Pharm Bull; 2000 Aug; 23(8):968-72. PubMed ID: 10963305
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
Hayton WL; Vlahov V; Bacracheva N; Viachki I; Portmann R; Muirhead G; Stoeckel K; Weidekamm E
Antimicrob Agents Chemother; 1990 Dec; 34(12):2375-80. PubMed ID: 2128442
[TBL] [Abstract][Full Text] [Related]
14. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
[TBL] [Abstract][Full Text] [Related]
15. Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses.
Bertino JS; Nafziger AN; Wong M; Stragand L; Puleo C
Antimicrob Agents Chemother; 1994 Mar; 38(3):499-503. PubMed ID: 8203844
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
Chukwuani CM; Coker HA; Oduola AM; Ifudu ND; Sowunmi A
Chemotherapy; 1998; 44(6):369-76. PubMed ID: 9755295
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of fleroxacin in man.
Sörgel F; Seelmann R; Naber K; Metz R; Muth P
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():169-78. PubMed ID: 3144535
[TBL] [Abstract][Full Text] [Related]
18. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
[TBL] [Abstract][Full Text] [Related]
19. Nitrofurantoin excretion in human milk.
Pons G; Rey E; Richard MO; Vauzelle F; Francoual C; Moran C; d'Athis P; Badoual J; Olive G
Dev Pharmacol Ther; 1990; 14(3):148-52. PubMed ID: 2364853
[TBL] [Abstract][Full Text] [Related]
20. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women.
Blode H; Foidart JM; Heithecker R
Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):167-71. PubMed ID: 11763981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
